Lam Research: Dual Engines Of Growth Make It Worth Buying On Pullbacks — Positive

LRCX   Seeking Alpha — October 27, 2025

Lam Research enters FY26 with strong foundry momentum and rising memory exposure. Foundry mix reached 60 percent, while NAND and HBM tools are set to drive 2026 growth. Valuation is rich, but memory upcycles historically benefit LRCX more than peers.

image for news Lam Research: Dual Engines Of Growth Make It Worth Buying On Pullbacks

Microsoft: Ultra-Bullish Heading Into Q1 2026 Earnings — Positive

MSFT   Seeking Alpha — October 27, 2025

I expect Microsoft Corporation's Intelligent Cloud/Azure to hit guidance ($28.6B – $28.9B for IC and 28–29% CC for Azure) given supply-constrained demand and pricing leverage, with no sign of a slowdown. AI adoption is the key catalyst, with 80% of the Fortune 500 using Azure AI Foundry and a 7x increase in tokens served by the Azure Foundry API in FY25. On the risk side, the aggressive AI buildout pressures GAAP EPS and margins. Considering the CapEx guidance of $30B for Q1 FY26, depreciation costs are already depressing gross margins.

image for news Microsoft: Ultra-Bullish Heading Into Q1 2026 Earnings

SAN FRANCISCO--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced seven-year data from the PARTNER 3 trial, reaffirming the early and sustained patient benefits of Edwards TAVR. The data, which showed superior clinical outcomes at one year, also demonstrate excellent long-term valve performance and durability. Separately, 10-year results from PARTNER 2 intermediate risk studies reinforce Edwards' leadership in setting the standard for lasting valve performance and excellent patien.

image for news Edwards SAPIEN 3 TAVR Delivers Proven Long-term Benefits and Valve Performance, New Data Presented at TCT 2025

Milei's Clear-Cut Victory Unlocks a Wall Street Windfall — Positive

ARGT   WSJ — October 27, 2025

The win for Argentine President Javier Milei's party is rewarding investors who bet on the country.

image for news Milei's Clear-Cut Victory Unlocks a Wall Street Windfall

Rare earth stocks find themselves underground on Monday as Treasury Secretary Scott Bessent said he expects that China and the U.S. will work out a trade deal in the near future.

image for news Markets are soaring today—with this exception. Here's why these stocks are dropping double digits

Alphyn Capital Management's Q3 2025 Top And Bottom Performers — Neutral

BN  BUR  CCOI  FRFHF  GOOG  MLSPF  PROSY  TRRVF  WANSF   Seeking Alpha — October 27, 2025

Alphabet's shares rose this quarter, partly driven by the resolution of a major regulatory overhang. Prosus's valuation has historically been dominated by its largest holding, Tencent. The Brookfield machine continues to compound intrinsic value, delivering robust Q2 results across its diversified platform.

image for news Alphyn Capital Management's Q3 2025 Top And Bottom Performers

Joby's Q3 Could Change Everything, Testing The Valuation — Positive

JOBY   Seeking Alpha — October 27, 2025

Joby Aviation's stock is up 24% since my last "Strong Buy" rating, driven by liquidity confidence and FAA progress. The $591 million equity raise at $16.85 per share boosted cash reserves to $1.6 billion, removing funding risk through 2027. Q3 consensus expects EPS of -$0.19 and revenue of $2.3 million, with investors focused on FAA Stage 4 and TIA readiness.

image for news Joby's Q3 Could Change Everything, Testing The Valuation

AXIL Upgraded to Outperform on Retail-Driven Operating Leverage — Positive

AXIL   Zacks Investment Research — October 27, 2025

Zacks upgrades AXIL Brands to "Outperform" on accelerating operating leverage from retail expansion, strong cost control and improving profitability, driven by entry into national chains like Costco.

image for news AXIL Upgraded to Outperform on Retail-Driven Operating Leverage

Portnoy Law Firm Announces Class Action on Behalf of Dow, Inc. Investors — Neutral

DOW   GlobeNewsWire — October 27, 2025

LOS ANGELES, Oct. 27, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Dow, Inc., (“Dow” or the "Company") (NYSE: DOW) investors off a class action on behalf of investors that bought securities between January 30, 2025 and July 23, 2025, inclusive (the “Class Period”). Dow investors have until October 28, 2025 to file a lead plaintiff motion.

image for news Portnoy Law Firm Announces Class Action on Behalf of Dow, Inc. Investors

Apple and Microsoft are racing to join Nvidia in an elite club — Positive

AAPL  MSFT  NVDA   Market Watch — October 27, 2025

Nvidia became a $4 trillion company in July. Now Apple and Microsoft are within a hair of the milestone.

image for news Apple and Microsoft are racing to join Nvidia in an elite club

Can Centene's Q3 Earnings Escape Industry's Cost Headwinds? — Neutral

CNC   Zacks Investment Research — October 27, 2025

CNC braces for Q3 results as revenue growth may be offset by rising medical costs and shrinking Medicaid memberships.

image for news Can Centene's Q3 Earnings Escape Industry's Cost Headwinds?

Meta: Placing The AI Bet — Positive

META   Seeking Alpha — October 27, 2025

Meta Platforms is aggressively investing in AI infrastructure to integrate "superintelligence" across its social media and advertising platforms. META's business strategy focuses on five key opportunities: Improved advertising, engaging experiences, business messaging, Meta AI, and AI devices. Significant capital expenditures are planned through 2026 to support AI development, with leadership transparent about potential short-term financial impact.

image for news Meta: Placing The AI Bet

CVS Health: Slow And Steady Wins The Healthcare Race — Positive

CVS   Seeking Alpha — October 27, 2025

CVS Health Corporation is rated a Buy with an 18% upside to a $97 price target, citing robust business momentum and undervaluation. CVS posted a strong FQ2 2025 double-beat, with revenue up 8.4% and continued double-digit growth in health services and pharmacy segments. CVS stock trades at a significant valuation discount to sector and market averages, despite steady top-line growth and a 3.25% dividend yield.

image for news CVS Health: Slow And Steady Wins The Healthcare Race

SAN FRANCISCO, Oct. 27, 2025 (GLOBE NEWSWIRE) -- A class-action lawsuit has been filed against James Hardie Industries plc (NYSE: JHX), the dominant producer of fiber cement building materials in the U.S., alleging the company committed securities fraud by misleading investors about inventory levels and customer demand in its crucial North American segment.

image for news James Hardie Industries (JHX) Lawsuit Alleges Securities Fraud Over Inventory Misstatements -- Hagens Berman

InMode: Discounted Valuation & Strong Fundamentals Make It A Buy — Positive

INMD   Seeking Alpha — October 27, 2025

InMode presents an appealing buy opportunity, trading near 52-week lows with strong fundamentals, innovative technology, and global expansion. INMD's minimally invasive platforms drive revenue growth, with international markets and new product launches supporting diversification and future potential. Despite regulatory, tariff, and demand risks, INMD maintains robust margins, a strong cash position, and disciplined cost control, ensuring operational resilience.

image for news InMode: Discounted Valuation & Strong Fundamentals Make It A Buy

NEW YORK--(BUSINESS WIRE)---- $JHX #Attorneys--Leading securities law firm BFA announces that a securities fraud class action lawsuit has been filed against James Hardie (JHX) after stock drop.

image for news BREAKING NEWS: James Hardie Industries plc Hit with Securities Class Action after Destocking Announcement causes 34% Stock Drop; Contact BFA Law by December 23 Court Deadline

PARSIPPANY, N.J., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Lincoln Educational Services Corporation (Nasdaq: LINC) (“Lincoln”) announced today that it will host a conference call to discuss its third quarter financial results on Monday, November 10, 2025 at 10:00 a.m. Eastern time. A news release outlining Lincoln's results will be issued before 9:30 a.m. Eastern time on that day.

image for news Lincoln Educational Services Corporation Schedules Third Quarter Earnings Release and Conference Call

What's in the Offing for Ventas Stock This Earnings Season? — Negative

VTR   Zacks Investment Research — October 27, 2025

While VTR's Q3 earnings are likely to have benefited from SHOP operating trends and a well-diversified tenant base, high interest expenses may have hurt it.

image for news What's in the Offing for Ventas Stock This Earnings Season?

FTI Consulting Stock Moves Up 2.7% Since Q3 Earnings Beat — Positive

FCN   Zacks Investment Research — October 27, 2025

FCN beat earnings estimates with stronger margins and segment gains, driving a 2.7% post-earnings stock rise.

image for news FTI Consulting Stock Moves Up 2.7% Since Q3 Earnings Beat

International Paper Set to Report Q3 Earnings: Here's What to Expect — Negative

IP   Zacks Investment Research — October 27, 2025

IP's Q3 results are anticipated to reflect strong growth from its DS Smith deal, even as weak packaging demand pressures the overall performance.

image for news International Paper Set to Report Q3 Earnings: Here's What to Expect